- 专利标题： QUINOLINAMINE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN PHARMACEUTICALS
-
申请号： US18564512申请日： 2022-05-27
-
公开(公告)号： US20240327388A1公开(公告)日： 2024-10-03
- 发明人: Fanglong YANG , Minqiang JIA , Huanyu TANG , Yonglei QUE , Feng HE , Weikang TAO
- 申请人： JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. , SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD.
- 申请人地址： CN Lianyungang
- 专利权人： JIANGSU HENGRUI PHARMACEUTICALS CO., LTD.,SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD.
- 当前专利权人： JIANGSU HENGRUI PHARMACEUTICALS CO., LTD.,SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD.
- 当前专利权人地址： CN Lianyungang
- 优先权： CN 2110606803.1 2021.05.27 CN 2110976020.2 2021.08.24
- 国际申请： PCT/CN2022/095441 2022.05.27
- 进入国家日期： 2023-11-27
- 主分类号： C07D405/12
- IPC分类号： C07D405/12 ; A61K31/4709 ; A61K31/473 ; A61K31/706 ; A61P37/06 ; C07D215/38 ; C07D401/12 ; C07D405/14 ; C07D413/12 ; C07D491/056 ; C07H1/00 ; C07H17/04
摘要：
The present invention relates to a quinolinamine compound, a preparation method therefor and an application thereof in pharmaceuticals. Specifically, the present invention relates to a quinolinamine compound as represented by general formula (I), a preparation method therefor, a pharmaceutical composition containing the compound, and use thereof as a therapeutic agent, especially use thereof as a miRNA regulator and use thereof in preparation of a drug for treating diseases or conditions that can be improved by regulating miRNA levels.
信息查询
